Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate by Aeschlimann, Daniel et al.
Transglutaminase-catalyzed Matrix Cross-linking in 
Differentiating Cartilage: Identification of 
Osteonectin as a Major Glutaminyl Substrate 
Daniel Aeschlimann, Oliver Kaupp, and Mats Paulsson 
M. E. Miiller-Institute for Biomechanics, University of Bern, CH-3010 Bern, Switzerland 
Abstract. The expression of tissue transglutaminase in 
skeletal tissues is strictly regulated and correlates with 
chondrocyte differentiation and cartilage calcification 
in endochondral bone formation and in maturation of 
tracheal cartilage (Aeschlimann, D., A. Wetterwald, 
H. Fleisch, and M. Paulsson. 1993. J. Cell Biol. 
120:1461-1470). We now demonstrate he trans- 
glutaminase reaction product, the 3,-glutamyl-e-lysine 
cross-link, in the matrix of hypertrophic cartilage 
using a novel cross-link specific antibody. Incorpora- 
tion of the synthetic transglutaminase substrate 
monodansylcadaverine (amine donor) in cultured tra- 
cheal explants reveals enzyme activity in the pericellu- 
lar matrix of hypertrophic chondrocytes in the central, 
calcifying areas of the horseshoe-shaped cartilages. 
One predominant glutaminyl substrate (amine accep- 
tor) in the chondrocyte matrix is osteonectin as re- 
vealed by incorporation of the dansyl abel in culture. 
Indeed, nonreducible osteonectin-containing complexes 
of *65, 90, and 175 kD can be extracted from mature 
tracheal cartilage. In vitro cross-linking of osteonectin 
by tissue transglutaminase gives similar products of 
,,o90 and 175 kD, indicating that the complexes in car- 
tilage represent osteonectin oligomers. The demonstra- 
tion of extracellular t ansglutaminase activity n 
differentiating cartilage, i.e., cross-linking of osteo- 
nectin in situ, shows that tissue transglutaminase- 
catalyzed cross-linking is a physiological mechanism 
for cartilage matrix stabilization. 
ONG bone development and growth ccurs by endochon- 
dral ossification (Hunziker and Schenk, 1989; So- 
lursh, 1989). In this process chondrocytes pass 
through a series of differentiation stages in which they rap- 
idly proliferate, synthesize matrix constituents at high rate 
and become hypertrophic, before the cartilage matrix cal- 
cifies. The calcified matrix is subsequently replaced by bone. 
The differentiating chondrocytes also change their repertoire 
of biosynthetic products and express e.g., collagen X, os- 
teopontin, and osteonectin (for references see Aeschlimann 
et al., 1993). Rat tracheal cartilage undergoes maturation 
and calcification in a manner esembling chondrocyte dif- 
ferentiation during endochondral bone formation (Aeschli- 
mann et al., 1993), with the exception that matrix calcifica- 
tion is not followed by cartilage resorption, vascularization, 
and bone formation. 
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We previously reported that tissue transglutaminase is 
synthesized and externalized by terminally differentiating 
chondrocytes both in endochondral bone formation and in 
maturation of tracheal cartilage (Aeschlimann et l., 1993). 
The transglutaminase catalyzes the posttranslational mod- 
ification of proteins referred to as R-glutamyl-peptide, amine- 
3,-glutamyl transfer reaction (EC 2.3.2.13). The Ca2+-depen - 
dent reaction results in theformation of new 3,-amide bonds 
between 3,-carboxamide groups of peptide-bound glutamine 
residues and various primary amines (for review see Folk 
and Fi layson, 1977; Lorand and Conrad, 1984). Most com- 
monly, 3,-glutamyl-e-lysine cross-links are formed in or 
between proteins by reaction with e-amino gr ups of pep- 
tide-bound lysine residues. Osteonectin is a potent in vitro 
glutaminyl substrate for tissue transglutaminase and is 
coexpressed with the enzyme in differentiating cartilage 
(Aeschlimann et al., 1993). It appears that tissue transglu- 
taminase may function in cartilage by cross-linking matrix 
proteins like osteonectin before mineralization of the tissue. 
Osteonectin was initially identified as one of the most 
abundant noncollagenous proteins in bone (Termine et al., 
1981a; Bolander et al., 1988), but is also widely distributed 
in other tissues, although in lower amounts (Dziadek et al., 
1986; Mason et al., 1986; Stenner t al., 1986; Lankat- 
Buttgereit et al., 1988). It has been implicated in the miner- 
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alization of cartilage and bone because it contains multiple 
calcium-binding domains, one of them in the form of an EF- 
hand (Engel et al., 1987; Maurer et al., 1992), and appears 
to have affinity for hydroxy-apatite (Termine et al., 1981b). 
However, as osteonectin s not bone specific, this line of 
reasoning is insufficient to explain all biological functions of 
this protein, and tissue-specific posttranslational modifica- 
tions may modulate some of its functions (Kelm and Mann, 
1991). 
Transglutaminases form a large protein family, with mem- 
bers specialized for protein cross-linking indifferent biologi- 
cal systems (Aeschlimann and Paulsson, 1994). Examples 
are the stabilization ofthe fibrin clot in hemostasis by the ac- 
tivated plasma transglutaminase, factor XHIa, and the role 
of transglutaminases in the process of physiological cell 
death, e.g., in the formation of the cornified envelope by 
epidermal transglutaminases in keratinocyte rminal dif- 
ferentiation, and in the cross-linking of membrane and cyto- 
skeletal components by tissue transglutaminase in aging of 
erythrocytes (Lorand and Conrad, 1984; Aeschlimann and 
Paulsson, 1994). Tissue transglutaminase may also play a 
role in programmed death of other cells since it accumulates 
in the cytoplasm of e.g., hepatocytes undergoing terminal 
differentiation both in vivo and in vitro (for review see F6sus 
et al., 1991). There is also increasing evidence for the occur- 
rence of tissue transglutaminase-catalyzed reactions outside 
the cell, although the mechanism ofenzyme xternalization 
remains unclear (Aeschlimann and Paulsson, 1991; Aesch- 
limann et al., 1993). This evidence includes the identifica- 
tion of a number of different extracellular matrix proteins as 
specific glutaminyl substrates (for references see Aeschli- 
mann et al., 1992; Aeschlimann and Paulsson, 1994), the 
demonstration of tissue transglutaminase activity in the 
pericellular matrix of cultured hepatocytes and endothelial 
cells (Barsigian et al., 1991, and references therein), and of
tissue transglutaminase protein in various extracellular ma- 
trices in vivo (Aeschlimann and Paulsson, 1991; Aesch- 
limann et al., 1993). Extracellular tissue transglutaminase 
may play a role in the assembly of the matrix, but also in 
events related to wound healing and excessive tissue repair 
since active enzyme binds to the extracetlular matrix with 
high affinity after wounding of cells (Upchurch et al., 1991) 
and may modulate matrix production by regulating the con- 
version of latent into active TGF-B (Kojima et al., 1993). 
The present study concerns the expression of transglu- 
taminase activity during cartilage maturation and the iden- 
tification of substrate proteins in cartilage cross-linked by 
transglutaminases in situ. The preparation of antibodies 
specific for the ,y-glutamyl-e-lysine cross-link allowed the 
immunohistochemical analysis of tissues for cross-linking 
by transglutaminases in vivo. Transglutaminase cross-link- 
ing in cartilage was predominant in the hypertrophic zone of 
long bone growth plate and of maturing trachea. Explant cul- 
ture of rat trachea in the presence of the transglutaminase 
amine donor substrate monodansylcadaverine ev aled en- 
zyme activity in the pericellular matrix of the chondrocytes 
in the calcifying areas. Osteonectin was identified as one pre- 
dominant target protein for cross-linking inthis tissue. These 
findings further support the physiological importance of(tis- 
sue) transglutaminase-catalyzed cross-linking in extracellu- 
lar matrices. 
Materials and Methods 
Organ Culture 
Tracheae were prepared under aseptic onditions from rats of defined age, 
cut longitudinally into halves, rinsed extensively with Earle's balanced salt 
solution, and cultured in medium M-199, containing 10% fetal calf serum 
and penicillin (100 U/ml), streptomycin (100/~g/ml), and fungizone (2.5 
/,g/nil). (All cell culture reagents were from GIBCO BRL, Gaithersburg, 
MD.) The explants were maintained in 24-well plates with ~0.5 ml 
medium, a volume sufficient to just cover the tissue pieces. The tracheae 
were allowed to adapt o the culture conditions for 4 d with two medium 
changes before pulse-labeling with 0.1 or 0.5 mM of the transglutaminase 
substrate monodansylcadaverine (N-[5'-aminopentyl]-5-dimethylamino-1- 
naphthalene sulfonamide; Sigma Immunochemicals, St. Louis, MO) for 
24 h, followed by a 24-h chase period. Control cultures were treated with 
the substrate analogue dansylamidopentanol (0.1 or 0.5 mM, see below). The 
dansyl compounds were dissolved in 0.1 M HCI and diluted 1:250 in the 
medium. The pH of the medium was readjusted and the concentration of 
either label verified by absorbance measurement at 335 nm. Cell viability 
was verified by pulse-labeling with 40 tzCi/ml L-[35S]methionine (1,000 
Ci/mmol, Amersham Corp., Amersham, UK) after treatment with either 
substance. The cultured tracheae were rinsed with Earle's balanced salt so- 
lution before further processing as described below. 
Dansylamidopentanol (N-[5'-hydroxypentyl]-5-dimethylamino-naphtha- 
lene-l-sulfonamide) was synthesized from l-amino-5-pentanol (0.9 g) dis- 
solved in 10 ml ethanol by dropwise addition of dansylchloride (I.0 g; Fluka, 
Buchs, Switzerland) issolved in 8.9 ml ether and 1.1 ml triethylamine with 
stirring for 2 h in the dark. The yellow oil obtained after evaporation ofthe 
solvent was dissolved in ether and extracted repeatedly with 50 mM HCI. 
The aqueous phases were combined and reextracted with a small volume 
of CHCI3. After evaporation of the solvent, the yellow gum was dissolved 
in a small volume of 50 mM HC1 and the product precipitated by addition 
of ,'~100 ml 0.2 M ammonium hydrogen carbonate. Dansylamidopentanol 
was allowed to crystallize from this olution at pH 9.0 and 4°C for 3-10 d. 
The pH was readjusted repeatedly. The product was recrystallized from 
0.2 M ammonium hydrogen carbonate giving a final yield of 500-600 mg. 
The purity of the product was verified by TLC (Kieselge160; Merck, Darm- 
stadt, Germany) in acetone and examination under UV light or after iodine 
staining. The identity of the product was confirmed by infrared spectros- 
copy (R-SO2-N: 1150 and 1310 cm -t, -OH: 3520 cm-t), the absorbance 
spectrum (absmax of fluorophore: 335 nm), and mass spectroscopy (experi- 
mentally determined: Mr = 336, M ÷l , 20.88%; M ÷2, 6.54%; calculated: 
Mr = 336; M +l, 20.90%; M +~, 5.03%). 
Protein Reagents 
Tissue transglutaminase was purified from guinea pig liver (Connellan et 
al., 1971). Osteonectin was prepared from young adult rat long bone accord- 
ing to a modification of the procedure established for the human protein by 
Fisher et al. (1987). A purity of >90% was achieved after two additional 
chromatographic steps, i.e., on hydroxyapatite (Bio-Gel HTP; Bio-Rad 
Laboratories, Hercules, CA), eluted with a linear gradient of 10-500 mM 
sodium phosphate, pH 6.8, in 7 M urea, and on Mono S (fast protein liquid 
chromatography [FPLC]I; Pharmacia LKB Biotechnology, Inc., Uppsala, 
Sweden), eluted with a linear gradient of 0-0.5 M NaC1 in 20 mM sodium 
acetate, pH 4.8, 7 M urea. The rat osteonectin was finally characterized by
NH2-terminal sequencing after separation by SDS-PAGE and blotting to 
polyvinylidene difluoride membrane (Immobilon P; Millipore, Bedford, 
MA) as described (Aeschlimann et al., 1992). Native recombinant human 
BM-40/osteonectin (Nischt et al., 1991) was kindly provided by Dr. R. 
Timpl (Max-Planck-Institute for Biochemistry, Germany). 
Antisera to guinea pig tissue transglutaminase (A schlimann and Pauls- 
son, 1991), rat osteonectin, and dansylated (hapten) hemocyanin (Aes- 
chlimann et al., 1993) were raised in rabbits and affinity purified when 
needed (Aeschlimann and Paulsson, 1991). A monoclonal ntibody against 
collagen type II (CIICI;. Holmdahl et al., 1986) was from the Developmen- 
tal Studies Hybridoma Bank (University of Iowa) and antisera to mouse and 
human BM-40/osteonectin were generously supplied by Dr. R. Timpl. 
An antiserum to the transglutaminase cross-link was raised against a 
1. Abbreviation used in this paper: FPLC, fast protein liquid chromatog- 
raphy. 
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Figure 1. Characterization of antibodies raised against he trans- 
glutaminase cross-link. (A) The antigen, [N,N-didansyl(3,-Glu-e- 
Lys)],hemocyanin, was coated to 96-weU plates (at 5/~g/ml) and 
detected with hemocyanin-adsorbed antiserum to the cross-link 
conjugate that had been preincubated with serial dilutions of',/-Glu- 
E-Lys ([]; C, structural formula a), N,-acetyl-Lys (e ;  C, b), Glu- 
~-ethylester ( - ;  C, c) or Na-acetyl-Lys (+ ; C, d), and peroxidase- 
hemocyanin conjugate. The ~-Glu-e-Lys dipeptide (50 mg; Sigma) was 
NH2-terminally blocked by dansylation i 9.6 mM sodium phosphate, pH 
7.4, 140 mM NaCI (PBS), using cyclohepta-amylose.dansylchloride (10- 
fold molar excess) as described (Aeschlimann et al., 1993)• The product 
was purified on a Bio-Gel P-2 column (Bio-Rad) in the same buffer (record- 
ing of absorbance at 335 rim) and coupled to Limulus polyphemus hemocya- 
nin (10 nag; Sigma) via its free carboxyl groups by a modified carbodiimide 
protocol (Staros et al., 1986). The protein conjugate was finally separated 
from low molecular mass compounds on a PD-10 column (Pharmacia LKB 
Nuclear, Gaithersburg, MD), equilibrated in PBS, and used for antibody 
production in rabbits (250 /xg/injection) asdescribed (Aeschlimann and 
Paulsson, 1991). The antiserum was adsorbed either with a hemocya- 
nin-Sepharose matrix (Aeschlimann a d Paulsson, 1991) or with a 
Sepharose affinity matrix obtained by coupling a N~-acetyl-Lys-hemocya- 
nin conjugate (obtained as described above) to remove contaminating hemo- 
cyanin antibodies and antibodies cross-reactive with N~-acetyl-Lys, respec- 
tively, and the specificity verified in an inhibition-style ELISA (Fig. 1). 
Histochemical Methods 
Tissues were frozen on dry ice in Tissue-Tel~ (Miles, Inc., Naperville, IL). 
For immunohistochemistry, 5-t~m sections were cut, adsorbed to gelatin- 
coated slides, air dried, and immunolabeled with theindicated antibodies 
using the peroxidase protocol as previously described (Aeschlimann etal., 
1993). To increase antibody penetration, sections were demineralized in 
TBS (50 mM Tris-HCl, pH 7.4, 0.15 M NaCI) containing 0.42 M EDTA 
and digested for 1 h with 40 mU/nd chondroitinase ABC (Seikagaku Corp., 
Tokyo, Japan) in 0.1 M Tris-HCl, 0.1 M sodium acetate, pH 7.4, containing 
0.01% (wt/vol) bovine serum albumin, where indicated. Calcification of tis- 
sues was visualized by yon Kossa's stain for calcium phosphate (Schenk et 
al., 1984). For autoradiography, sections were exposed to Kodak NTB-2 
liquid emulsion. 
Protein Extraction from Tracheal Cartilage 
Tracheal cartilage was dissected from adhering soft tissue and, when ob- 
tained from explant cultures, briefly homogenized in 10 ml/g wet tissue of 
4 M guanidine HCI, 50 mM Tris-HCl, pH 6.0, containing 0.1 M EDTA and 
the protease inhibitors N-ethylmaleimide (1 mM NEM), PMSF (1 mM), 
benzamidine (10 mM), and 6-aminohexanoic a id (0.1 M), and extracted 
by stirring for 2 h at room temperature. Directly isolated c rtilage was se- 
quentially extracted by homogenization in 13 ml/g wet tissue of (a) ice-cold 
50 mM Tris-HCl, pH 7.4, containing 0.15 M NaCI and the protease inhibi- 
tors, and by stirring for 2 h at 4°C in b the same buffer containing inaddition 
0.42 M EDTA and in c 4 M guanidine HCI, 50 mM Tris-HCl, pH 7.4, con- 
taining 0.42 M EDTA and the protease inhibitors. The homogenates were 
centrifuged at 35,000 g for 20 min, and extracted proteins precipitated from 
the supernatants with ice-cold ethanol (1:9 vol/vol). The precipitates were 
collected by centrifugation a d resuspended by boiling in SDS-PAGE sam- 
ple mixture containing 4 M urea• 
Digestion of cartilage from cultured tracheal explants was performed 
with 20 mg ot-chymotrypsin (bovine pancreas, 45 U/mg; Serva Biochemi- 
cals, Paramus, NJ)/g wet tissue in 50 mM Tris-HCl, pH 7.4, 0.15 M NaCI, 
0.1 M EDTA, and 10 mM NEM for 48 h at room temperature while shaking. 
The digestion was stopped by addition of a concentrated stock solution to 
yield the same 4 M guanidine HCI-extraction buffer as above, in this in- 
stance containing 10 mM PMSF, and the tissue extracted as above. 
conjugated secondary antibodies. (Other compounds tested and 
found to be noninhibitory include N~-acetyl-Gln, N~-carbobenz- 
oxy-Gln-Gly, Lys, and Na-acetyl-Lys-methylester). The residual 
reactivity of the adsorbed antiserum isdirected mainly to the dansyl 
group, a synthetic compound that has no structural analogue in bio- 
logical systems. The results are shown as a mean of two determina- 
tions. (B) The antiserum was adsorbed with a Sepharose affinity 
matrix made from a N,-acetyl-Lys-hemocyanln conjugate to re- 
move antibodies cross-reactive with N,-acetyl-Lys and was subse- 
quently tested as above (El, "y-Glu-e-Lys; e ,  N~-acetyl-Lys). (C) 
Structural formulas of the various inhibitors are represented, with 
parts differing from the transglutaminase cross-link structure 
printed in italics. 
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Transglutaminase Assay 
In vitro cross-linking ofrecombinant BM-40/osteonectin and incorporation 
of monodansylcadaverine into N,N-dimethylcasein (Serva) with tissue 
transglutaminase was done as described previously (Aeschlimann and 
Paulsson, 1991). 
SDS-PAGE and lmmunoblotting 
SDS-PAGE (Laemmli, 1970) was done in 4-20% gradient gels. Proteins 
were reduced with 2-mercaptoethanoi (1% vol/vol) when desired, andde- 
tected by staining with Coomassie brilliant blue R or immunocbemically 
after transfer onto i rocellulose (Towbin et al., 1979). Binding of primary 
antibody was visualized using peroxidase-conjugated swine anti-rabbit IgG 
(Dakopatts, Glostrup, Denmark) and the ECL kit (Amersham) according 
to the manufacturer's protocol. Stripping and reprobing of membranes was 
done as described (ECL kit). When using the antibodies to the trans- 
glutaminase cross-link, nonspecific binding was blocked with bovine serum 
albumin, which had been shown not to be a transglutaminase substrate 
(Aeschlimann a d Paulsson, 1991) and does therefore notcontain cross-link 
epitopes, and binding of primary antibodies wa  detected with 35S-labeled 
donkey anti-rabbit IgG (Amersham). 
Results 
Characterization of the Antibodies to the 
Transglutaminase Cross-link 
To demonstrate transglutaminase cross-linking in vivo we 
raised polyclonal ntibodies against the unique reaction 
product of these enzymes, the 3,-Glu-e-Lys dipeptide. For 
this purpose the dipeptide was coupled to hemocyanin after 
blockage of amino groups by dansylation ([N,N-didansyl(3,- 
Glu-~-Lys)]ohemocyanin). The antiserum was purified by 
adsorption to a hemocyanin-Sepharose matrix and the spec- 
ificity of the remaining antibodies was tested in an inhibition- 
style ELISA (Fig. 1 A). Among the structural analogues to 
the antigen tested, only -/-Glu-e-Lys and N,-acetyl-Lys were 
able to inhibit antibody binding at concentrations below 20 
mM (3,-Glu-E-Lys gave half-maximal inhibition at ,x,10/~M, 
N,-acetyl-Lys at three- to fourfold higher concentration). 
The reactivity of the antibodies with N,-acetyl-Lys was ex- 
pected as the compound is structurally identical to "g-Glu-e- 
Lys but smaller (Fig, 1 C). The maximum inhibition with 
N,-acetyl-Lys is lower, indicating that a subpopulation 
(~22%) of the antibodies recognizing the ,y-Glu-~-Lys di- 
peptide is completely specific for the cross-link. This 
antibody population was further purified by adsorption of 
the antiserum to a N,-acetyl-Lys-hemocyanin-Sepharose 
matrix, giving a fraction of antibodies that is inhibited by 
N,-acetyl-Lys only at >l,000-fold higher concentrations 
than of ~-Glu-E-Lys (Fig. 1 B). N~-acetylation of lysines 
occurs physiologically in nuclear proteins (Turner, 1991) 
while transglutaminase cross-linking has been reported 
in the cytosol, at the plasma membrane, and in the extracel- 
lular space (Aeschlimann and Paulsson, 1994). The com- 
partmentalization f the respective reactions as well as the 
removal of cross-reactive antibodies allows discrimination 
between these structures. 
To further demonstrate he specificity of the antibodies, we 
performed immunostaining on skin and immunoblotting on 
in vitro cross-linked proteins (Fig. 2). The massive intracel- 
lular cross-linking by epidermal transglutaminases in termi- 
nal differentiation of keratinocytes leads to the formation of 
the cornified envelopes (Thacher and Rice, 1985; Hohl et 
al., 1991; Kim et al., 1993; Aeschlimann and Paulsson, 
1994). Immunostaining with the novel antibodies revealed 
increasing levels of cross-linking in the upper spinous and 
granular layers of epidermis and in the stratum corneum 
(Fig. 2 A). This staining agrees with the expression pattern 
of keratinocyte transglutaminase (Thacher and Rice, 1985). 
Intense staining for the cross-link is also observed in the in- 
Figure 2. Detection of the transglutaminase cross-link on sections of skin and of in vitro cross-linked proteins by immunoblotting. 5-#m 
cryosections of rat paw skin (A and B) were incubated with antibodies specific to the transglutaminase cross-link (A; compare Fig. 1 B) 
or nonimmune serum (B), and developed using peroxidase-conjugated secondary antibodies. Tissue structures in skin are indicated as 
follows: basement membrane (BM), separating dermis (D), and epidermis (spinous layer [SS], granular layer [SG] and stratum corneum 
[SC]). Bar, 50 tzm. (C) Human recombinant osteonectin was incubated with guinea pig liver tissue transglutaminase in the presefice of 
lysine (1 mM) and either 25 mM EDTA (lane 1 ) or 5 mM Ca 2+ (lane 2) for 30 min at 37°C. The reaction mixture was subjected to SDS- 
PAGE under reducing conditions, then proteins were transferred to a nitrocellulose membrane and epitopes generated by the action of 
the Ca2+-dependent transglutaminase w re detected with the antibodies to the cross-link and 35S-labeled secondary antibodies. The pro- 
tein bands assigned to osteonectin (ON), osteonectin oligomers (9OK, 135K, 175K; compare Fig. 9), and tissue transglutaminase (tTG) 
are indicated on the right. 
The Journal of Cell Biology, Volume 129, 1995 884 
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ner root sheath of hair follicles (results not shown), consis- 
tent with the function of epidermal transglutaminase in 
cornification of this tissue (Kim et al., 1993; Lee et al., 
1993). In addition, transglutaminase cross-linking is ob- 
served in the basement membrane underlying epidermis 
(Fig. 2 A) and surrounding hair follicles (results not shown), 
presumably due to tissue transglutaminase (Lichti et al., 
1985) catalyzed cross-linking of e.g., nidogen and BM- 
40/osteonectin (Aeschlimann and Paulsson, 1991; Aeschli- 
mann et al., 1992). Incorporation oflysine into recombinant 
BM-40/osteonectin by tissue transglutaminase g nerated 
epitopes that are reactive with the antibodies to the cross- 
link (Fig. 2 C). The generation ofsuch epitopes also in tissue 
transglutaminase i  due to the autocatalytic a tivity of the 
enzyme (Aeschlimann and Paulsson, 1991). 
Detection of the Transglutaminase Cross-link in 
Differentiating Cartilages 
Transglutaminase cross-links were revealed in the mineral- 
ized matrix of the hypertrophic zone of growth plate cartilage 
and in bone matrix of developing rat long bones by antibody 
labeling after decalcification of the tissue and digestion of 
glycosaminoglycans with chondroitinase ABC (Fig. 3 B). 
Preincubation of sections with Ca2÷-containing buffer gave 
labeling of also not digested and demineralized tissue, re- 
flecting the activation of the intracellular pool of transglu- 
taminase in the earlier chondrocyte maturation steps (Fig. 3 
D; large arrow) and in osteoblasts (Fig. 3 D; e.g., along the 
bone trabeculae). Control sections preincubated with EDTA- 
containing buffer were negative (similar to Fig. 3 A). This 
pattern of cross-linking in epiphyseal growth plate cartilage 
correlates with the distribution of tissue transglutaminase 
protein (Aeschlimann etal., 1993). The enzyme responsible 
for cross-linking of bone matrix is likely to be a different 
member of the transglutaminase protein family (Aeschli- 
mann et al., 1993). Transglutaminase cross-linking in the 
matrix of growth plate cartilage (Fig. 3 B, small arrow) oc- 
curs in parallel with the deposition of osteonectin (Fig. 3 E) 
and matrix mineralization (Fig. 3 C). 
In maturing tracheal cartilage, the transglutaminase cross- 
link was detected around the calcium phosphate mineral 
deposits in the center of the horseshoe-shaped cartilages 
(Fig. 3 F; compare with Fig. 6 C, inset), which is in agree- 
ment with the expression of tissue transglutaminase (A sch- 
limann et al., 1993). Foci of intense staining (arrowhead) 
appear to be single hypertrophic chondrocytes which are 
cross-linked intracellularly and/or in the pericellular matrix, 
Figure 3. Detection of the transglutaminase cross-link on sections 
of developing long bone and maturing tracheal cartilage. 5-#m 
cryosections of a newborn rat tarsal bone (A-E)and of a 9-wk-old 
rat tracheal cartilage (F and G) were incubated with antibodies 
specific to the transglutarninase cross-link (B, D, and F; compare 
Fig. 1 B), to osteonectin (E and G) or with nonspecific serum (A). 
Binding of primary antibodies was visualized using peroxidase- 
conjugated secondary antibodies. Sections A, B, E, F, and G were 
postfixed with methanol, decalcified and digested with chon- 
droitinase ABC before immunolabeling, while section D was prein- 
cubated with Ca~+-containing buffer (Aesehlimann et al., 1993). 
Mineralization was revealed by yon Kossa's tain for calcium phos- 
phate (C). Histologically discernible zones in long bones are 
marked (A). E, epiphysis; M, metaphysis; and D, di physis. Bars, 
50 #m. 
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while patchy staining areas ( mall arrow) indicate matrix 
cross-linking. Also the staining for immunoreactive os- 
teonectin i the periphery of the mineralized area occurs fre- 
quently in foci (Fig. 3 G, arrowhead). The absence of stain- 
ing for the cross-link in the fully mineralized matrix could 
be due to limited penetration of the antibodies even after" 
decalcification a d chondroitinase digestion. 
Characterization of the Cartilage Culture System Used 
to Detect Transglutaminase Activity In Situ 
To determine the physiological role of cartilage matrix cross- 
linking by transglutaminases, we developed an organ culture 
system for tracheal cartilage which allowed us to detect 
transglutaminase activity and target proteins for cross- 
linking in situ. We used the synthetic amine substrate 
monodansylcadaverine, previously used in other culture sys- 
tems (Cornwell et al., 1983; Kvedar et al., 1992) to detect 
transglutaminase ctivity and synthesized an inactive deriva- 
tive, dansylamidopentanol (Fig. 4 A) for use as a control. 
(The toxic concentration reported for dansyl compounds, 
i.e., monodansylcadaverine,  cell culture is •0.2 mM 
[Cornwell et al., 1983]. We observed etachment of cells 
from the substratum atthose concentrations of monodansyl- 
cadaverine and dansylamidopentanol with cultured A204 
human rhabdomyosarcoma cells [J.-P. Kleman, D. Aeschli- 
mann, M. Paulsson, and M. van der Rest, manuscript sub- 
mitted for publication], but we observed good viability at up 
to ,x,1 mM in tracheal explant culture. This higher tolerance 
is consistent with results obtained with skin explants [Kvedar 
et al., 1992] and might be explained by a diffusion gradient 
across the explants. We obtained i entical results when using 
N 
I 
O=S=O 
[ ~  I : R=NH 2 
I1: R=OH 
CH 3 CH 3 
A 
Figure 4. Tissue transglutaminase-catalyzed protein cross-li king 
in presence of monodansylcadaverine (dansylamidopentylamine) 
(A-C, I) or dansylamidopentanol (A-C, //). The structural for- 
mulas of the dansyl compounds are given in A. Gu ea pig liver tis- 
sue transglutaminase was incubated with N,N-dimethylcasein at pH 
7.0 in presence of either compound for 30 rain at 37°C, the reaction 
mixture separated by SDS-PAGE and the proteins stained with 
Coomassie blue (B) or after transfer to nitrocellulose by incubation 
with anti-dansyl antiserum (C). Mr standards and the top and bot- 
tom of the separating gel (arrows) are indicated on the left, the pro- 
tein bands assigned to N,N-dimethylcasein (CAS) and tissue trans- 
glutaminase (tTG) on the right. 
0.1 and 0.5 mM monodansylcadaverine and 0.5 mM monobi- 
otincadaverine [Lee et al., 1992] in our experiments.) We 
verified the validity of dansylamidopentanol as a control by 
incubation of tissue transglutaminase with the glutaminyl 
substrate protein N,N-dimethylcasein a d either monodan- 
sylcadaverine or dansylamidopentanol at various pH values 
(from 5 to 9). The reactions gave incorporation fthe amine, 
but not the alcohol (Fig. 4, B and C). Potential toxicity of 
the dansyl compounds at the concentrations u ed in culture 
(0.1 or 0.5 mM) could be excluded as metabolic labeling of 
the cultures with [3sS]methionine after treatment with ei- 
ther compound and quantitation of protein-bound radioac- 
tivity gave identical values as control cultures (results not 
shown; see also Fig. 7). 
Transglutaminase Activity Is Associated with 
Hypertrophic Chondrocytes in the Mineralizing Areas 
of Cultured Tracheae 
Tracheae of young adult rats were incubated in culture 
for 24 h with the transglutaminase substrate monodansyl- 
cadaverine or the substrate analogue dansylamidopentanol 
and chased in medium without label. Immunohistochemical 
detection of the dansyl group revealed that label was incorpo- 
rated in tissue incubated with the amine substrate, but not 
with the control derivative (Fig. 5, A and B). Staining was 
predominantly present in a ring around the chondrocytes, 
probably due to cross-linking of the dansyl label to proteins 
of the pericellular matrix and/or deposited at the intracellu- 
lar face of the plasma membrane (Fig. 5 C). The labeling 
intensity increased with chondrocyte maturation (Fig. 5 C) 
which proceeds towards the center of the tracheal cartilages 
where the tissue undergoes mineralization (Fig. 6). Trans- 
glutaminase activity is highest in the layer of hypertrophic 
chondrocytes surrounding the mineral deposits (Fig. 5 C). 
This activity pattern is consistent with the previously ob- 
served expression of tissue transglutaminase on the protein 
level (Aeschlimann et al., 199.3). Indeed, staining of serial 
sections for immunoreactive tissue transglutaminase nd for 
incorporated monodansylcadaverine rev aled coinciding pat- 
terns (results not shown). 
To determine the onset of transglutaminase activity during 
tracheal cartilage development we studied explants taken at 
different time points in the rat postnatal growth phase. In ex- 
plants from newborn rats, transglutaminase activity could 
not be detected (results not shown), consistent with the pre- 
viously observed absence of tissue transglutaminase protein 
at this stage in vivo (Aeschlimarm et al., 1993). In explants 
from 4-5-wk-old rats, the first cells expressing transglu- 
taminase activity were detectable in the center of a few tra- 
cheal cartilages, whereas in those from 6-7-wk-old rats, en- 
zyme activity was prominent in the hypertrophic zone of all 
horseshoe-shaped cartilages (Fig. 6, A and B). Mineraliza- 
tion started around week 7, corresponding tothe age of pu- 
berty (Fig. 6 B). Expression of transglutaminase activity 
preceded the onset of mineralization, i  agreement with the 
pattern seen in mature cartilage where enzyme activity is 
highest in the layer of hypertrophic chondrocytes adjacent to 
mineral deposits (Fig. 5 C). The occurrence of both pro- 
cesses in rapid succession i the postnatal development i di- 
cates that expression of active transglutaminase nd mineral- 
ization may be coupled. Explants from animals of eight 
weeks or older resemble the situation in adult animals where 
The Journal of Cell Biology, Volume 129, 1995 886 
 o
n
 M
arch 12, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published May 1, 1995
Figure 5. Detection of incorporated monodansylcadaverine on sections of tracheae after in sial labeling. Adult rat (•3 mo) tracheae were 
cultured for 24 h in the presence of 0.5 mM of either the transglutaminase substrate monodansylcadaverine (A an  C) or th control deriva- 
tive dansylamidopentanol (B) and chased in medium without label. The tissue was cryosectioned (5/zm), incubated with anti-dansyl antise- 
rum, developed with peroxidase-conjugated secondary antibodies (3-amino-9-ethylcarbazole/H202 used as peroxidase substrate solution: 
brown stain) and counterstained with Mayers H~rnalaun (blue stain). The calcified area in C is indicated by arrows. Bars, 50 ttrn. 
transglutaminase activity is observed in the hypertrophied 
and calcified areas of the horseshoe-shaped cartilages, but is 
absent from resting cartilage (Fig. 6 C). 
The apparent activation of the transglutaminase in the late 
stages of chondrocyte differentiation led us to examine the 
viability of the cells in the terminal differentiation program 
as externalization a d/or intracellular ctivation of the trans- 
glutaminase might occur by cell death in combination with 
membrane disintegration and leakage of intracellular com- 
ponents or a rise in intracellular [Ca2÷], respectively. Meta- 
bolic labeling of the cultures with [3sS]methionine, followed 
by autoradiography of tissue sections demonstrated that all 
chondrocytes were metabolically active (Fig. 7). No signs of 
cell death were seen in any stage of chondrocyte differentia- 
tion, and even cells fully embedded ina calcified matrix were 
active in protein synthesis (Fig. 7 C, arrowhead). Thus, the 
abundance of transglutaminase activity associated with all 
maturing chondrocytes is clearly not due to cell death. 
Substrate Proteins of the Endogenous 
Transglutaminase in Tracheal Cartilage 
Tracheal explants were labeled in culture and dissected car- 
tilages extracted with 4 M guanidine HC1 in the presence of 
inhibitors of transglutaminases (EDTA, N-ethylmaleimide) 
and proteases. SDS-PAGE and immunoblotting with anti- 
dansyl antibodies revealed covalent attachment ofthe dansyl 
compound to proteins from explants incubated with mono- 
dansylcadaverine (Fig. 8, lanes a and c), but not from ex- 
plants incubated with dansylamidopentanol (results not 
shown). Most of the dansyl label was detected inhigh molec- 
ular mass proteins or protein complexes, but a prominent 
glutaminyl substrate protein with an apparent molecular 
mass of ,o38 kD without and •43 kD with prior reduction 
can be clearly distinguished (Fig. 8, lanes a and c). The char- 
acteristic shift in mobility of this labeled protein following 
reduction resembles the behavior of osteonectin. Indeed, im- 
munoblots of the tracheal extract probed with antibodies to 
the dansyl moiety (Fig. 8, lanes a and c) and to osteonectin 
(Fig. 8, lanes b and d) reveal comigration of these proteins, 
supporting the identity of the dansyl-labeled protein with os- 
teonectin. Osteonectin with dansyl abel attached migrated 
slightly slower upon reduction than osteonectin without he 
modification, resulting in a doublet-band (Fig. 8, lanes c and 
d; compare Fig. 9, lane h). 
Extensive digestion of tracheae, labeled with monodansyl- 
cadaverine inculture, with ct-chymotrypsin before xtraction 
and immunoblotting with anti-dansyl antiserum, resulted in 
disappearance of the labeled high molecular mass proteins 
or protein complexes while fragments of an apparent molec- 
ular mass of ,o55, 60, and 100 kD were stable to further 
cleavage (Fig. 8, lane e). The ,,ol00-kD component was by 
immunoblotting shown to represent type II collagen (Fig. 8, 
lane f ) .  
The demonstration f cross-linking of the dansyl abel to 
extracellular matrix proteins, i.e., osteonectin a d collagen 
II (Fig. 8), shows that at least part of the transglutaminase 
activity associated with hypertrophic chondrocytes (Fig. 5) 
is present in the pericellular matrix. We cannot exclude that 
intracellular cross-linking does also occur, although the 
present results are in full agreement with an extracellu- 
lar cross-linking. This supports the previous immunohis- 
tochemical observation of an intracellular accumulation of
tissue transglutaminase in the early steps of chondrocyte 
differentiation and its subsequent externalization before min- 
eralization of the tissue (Aeschlimann et al., 1993). The un- 
masking of 3,-glutamyl-e-lysine cross-links in cartilage upon 
digestion with chondroitinase ABC (Fig. 3) is also consistent 
Aeschlimann et al. Transglutaminase Cross-linking in Cartilage Matrix 887 
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Figure 6. Transglutaminase activity in tracheal 
cartilage during the rat postnatal growth phase. 
Tracheal explants from 4- (A), 6- (B), and 8- (C) 
wk-old rats were incubated in culture with 0.5
mM monodansylcadaverine for 24 h and chased 
in medium without label. The tissue was cryo- 
sectioned (5 #m) and incorporated label de- 
tected with anti-dansyl antiserum and peroxi- 
dase-conjugated s condary antibodies. Calcium 
phosphate-containing mineral deposits were 
visualized by von Kossa's tain for calcium phos- 
phate, shown in the insets. Not all cartilages are 
at exactly the same developmental stage at a 
given time point as exemplified by the differing 
extent of mineralization in two neighboring 
cartilages in panel R Monodansylcadaverine 
incorporation is shown for a cartilage that has 
not yet become mineralized. Bar, 50 #m. 
with extraceUular t ansglutaminase activity. Indeed, im- 
munohistochemical detection of extracellular matrix pro- 
teins in cartilage, e.g., cartilage proteoglycan aggregate 
(Poole et al., 1982) or fibronectin (Mackie et al., 1987), 
does often reveal predominant s aining in the chondrocyte 
pericellular matrix, presumably due to masking of the pro- 
teins in the mature matrix. Further, incorporation of the 
transglntaminase into the matrix may lead to its inactivation 
as indicated by e.g., the presence of tissue transglutaminase 
antigen in the cartilage cores of bone trabeculae but lack of 
transglutaminase activity in this location (Aeschlimann et 
al., 1993). Pulse-labeling with monodansylcadaverine (Fig.
5) might reveal only the active enzyme in the newly depos- 
ited matrix. The demonstration of metabolic activity in 
chondrocytes xpressing high levels of transglutaminase ac-
tivity (Fig. 7) indicates that externalization f tissue trans- 
glutaminase must occur by a mechanism other than cellular 
disintegration. 
Osteonectin Is Present in Cross-linked Complexes in 
Skeletal Tissues In Vivo 
Adult rat tracheal cartilage was sequentially extracted with 
buffered saline, saline supplemented with EDTA, and a 4 M 
guanidine HC1/EDTA solution in presence of inhibitors of 
transglutaminases and proteases. SDS-PAGE and immuno- 
blotting with antibodies to osteonectin revealed several im- 
munoreactive bands of higher apparent molecular mass than 
the monomeric protein (Fig. 9). Bands of ,065, 90, and 175 
kD were resistant to reduction, even after boiling in urea and 
SDS (Fig. 9, lanes a-c). To exclude a contaminating reac- 
tivity in our antiserum to rat bone osteonectin we verified 
this result with an antiserum raised against he mouse En- 
gelbreth-Holm-Swarm tumor-derived protein (results not 
shown). Presumably, these bands represent covalenfly stabi- 
lized protein complexes with osteonectin asa constituent. In
vitro cross-linking of recombinant BM-40/osteonectin by tis- 
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Figure 7. Autoradiography of sections 
from cultured tracheae following meta- 
bolic labeling with [3sS]methionine. 
Tracheae of 4- (A), 6- (B), and 8- (C) wk- 
old rats were cultured in the presence of 
0.5 mM monodansylcadaverine, subse- 
quently pulse-labeled with [35S]methio- 
nine for 24 h and chased in medium with- 
out label. 5-/~m cryosections of the tissue 
were covered with photographic emulsion 
and exposed for 2 d. The photographic 
reaction was developed (black grains) and 
the tissue weakly counterstained with 
Mayers H~'nalann. The darker staining 
(Hiimalann) area in the center of the 
horseshoe-shaped cartilage in C indicates 
cartilage calcification. Bar, 50/~m. 
Figure 8. Analysis of trans- 
glutaminase substrate pro- 
teins in tracheal cartilage after 
in situ labeling with monodan- 
syleadaverine. Tracheae were 
cultured for 24 h in the pres- 
ence of 0.5 mM monodansyl- 
cadaverine and chased in 
medium without label. The 
proteins were extracted with 
4 M guanidine HC1 contain- 
ing buffer (in the presence of 
transglutaminase inhibitors), 
either directly (lanes a-d) or 
after extensive digestion of the 
tissue with ¢~-chymotrypsin 
(lanes e and f) ,  and separated 
in 4-20% SDS-polyaeryl- 
amide gels without (-SH) or 
with (+SH) prior reduction. 
Proteins were detected after 
transfer to nitrocellulose by 
incubation with antibodies to 
the dansyl moiety (lanes a, c, and e), to osteonectin (lanes b and d) or to collagen type II (lane f )  by stripping and reprobing the membranes. 
M, standards as well as top and bottom of the separating gels (arrows) are indicated on the left. The protein bands assigned to osteonectin 
and collagen type II are marked with the label ON and Col 1I, respectively. 
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Figure 9. Characterization f 
osteonectin and osteonectin 
complexes present in cartilage 
and bone. Proteins sequen- 
tially extracted from adult rat 
tracheal cartilage with buf- 
ered saline (lane a), contain- 
ing EDTA (lane b) and guani- 
dine HCI/EDTA (lane c), were 
separated by SDS-PAGE per- 
formed under reducing con- 
ditions and after transfer to 
nitrocellulose stained by incu- 
bation with antibodies to os- 
teonectin (lanes a-c). Osteo- 
nectin prepared from rat long bone was revealed by Coomassie blue staining after SDS-PAGE separation and transfer to polyvinylidene 
difluoride membrane (lane d). Human recombinant osteonectin was incubated with guinea pig liver tissue transglutaminase in presenc
of 25 mM EDTA (lane e), 5 mM Ca 2÷ (lanesfand g), or 5 mM Ca 2÷ and 20/~M monodansylcadaverine (lane h) for 30 min (lanes e, 
f, and h) or 2 h (lane g) at 37°C and the proteins were subsequently separated by SDS-PAGE and detected after transfer to nitrocellulose 
with antibodies to osteonectin. Mr standards as well as top and bottom of the separating gels (arrows) are indicated on the left. The 
protein bands assigned to osteonectin (ON), osteonectin-monodansylcadaverine complex (ON*), osteonectin oligomers (9OK, 135K, and 
175K) and a 65-kD osteonectin complex (65K) are indicated on the right. 
sue transglutaminase yi lds products which resemble the 90- 
and 175-kD osteonectin complexes i olated from cartilage, 
indicating that hese complexes represent osteonectin dimers 
and tetramers, respectively (Fig. 9, lanes e-g). Furthermore, 
incorporation of monodansylcadaverine into recombinant 
BM-40/osteonectin results in a slightly retarded migration of 
the protein in SDS-PAGE (Fig. 9, lane h), resembling the 
pattern observed in the cartilage xplant cultures with a 
doublet-band in the monomer position (compare Fig. 8, 
lanes c and d). A pattern of osteonectin-immunoreactive 
bands similar to that in tracheal cartilage xtracts was ob- 
tained in extracts from long bones and purification of os- 
teonectin from this source revealed, in addition to the mono- 
meric protein, a copurifying complex of ",~65 kD that was 
reactive with the antibodies to osteonectin (Fig. 9, lane d). 
NH2-terminal sequencing of the two bands with apparent 
molecular masses of 40 and 43 kD in the monomer position 
(Fig. 9, lane d) gave both the sequence APQTEAAEEM that 
is closely similar to APQQTEVAEEI previously determined 
for mouse osteonectin (Mason et al., 1986), confirming 
them to be the rat osteonectin homologue. The ,'~65-kD 
complex gave APQT, representing the NH2 terminus of os- 
teonectin, and GA(hydroxyP)GP, originating from a colla- 
gen. The collagen sequence was too short to be unambigu- 
ously assigned to the subtype. It remains however unclear if 
the complex represents osteonectin covalently bound to an- 
other component, e.g., a collagen fragment, or only os- 
teonectin, i.e., a degradation product of an oligomer. 
Discussion 
Amine incorporation i cultured tracheal explants revealed 
that in cartilage of adult rats, transglutaminase activity is 
predominantly associated with the chondrocytes surround- 
ing the calcium phosphate deposits, which phenotypically 
resemble the hypertrophic chondrocytes of long bone growth 
plate. During the postnatal development of trachea, trans- 
glutaminase activity could first be detected around chondro- 
cytes shortly before the onset of mineralization. This finding 
is consistent with the previously observed intracellular ac- 
cumulation and subsequent externalization f tissue trans- 
glutaminase protein by chondrocytes in the hypertrophic 
zone of long bone growth plate and trachea in vivo (Aesch- 
limann et al., 1993). Indeed, detection of the unique trans- 
glutaminase r action product, the 7-glutamyl-e-lysine cross- 
link, with a specific antibody on tissue sections revealed the 
cross-link in the hypertrophic cartilage of the epiphyseal 
growth plate and the mineralizing area of tracheal cartilages, 
but not in resting cartilage. The demonstration f amine in- 
corporation into matrix proteins in cultured tracheal ex- 
plants (Fig. 8) together with the detection of incorporated 
amine around differentiating chondrocytes (Fig. 5) suggests 
that the cross-linking occurs predominantly in the pericellu- 
lar matrix. The detection of 7-glutamine-e-lysine cross-links 
(Fig. 3) and tissue transglutaminase ntigen (Aeschlimann et 
al., 1993) in cartilage matrix and the requirement for depo- 
lymerization of glycosaminoglycan chains to unmask these 
epitopes are consistent with extracellular cross-linking. 
These results indicate that tissue transglutaminase expres- 
sion, externalization a d activation, and mineral formation 
are consecutive steps in the chondrocyte maturation program 
both during postnatal development of tracheal cartilage and 
in endochondral ossification. There is not necessarily a di- 
rect causal connection between these processes, even though 
transglutaminase-catalyzed cross-linking of the matrix could 
indeed alter its structure in a way that predisposes the tissue 
to calcification. Clustering of fixed charged groups by cross- 
linking of anionic matrix proteins, e.g., to the collagen fibril, 
might provide a surface which promotes nucleation and/or 
growth of hydroxyapatite crystals (Boskey, 1992). Osteonec- 
tin and osteopontin are present in mineralizing areas of carti- 
lage and bone (Mets/iranta et al., 1989; Aeschlimann et al., 
1993; Ikeda et al., 1992; Denhardt and Gut, 1993), are an- 
ionic and contain calcium-binding domains (Engel et al., 
1987; Maurer et al., 1992; Denhardt and Gut, 1993), and 
are transglutaminase substrates (Prince et al., 1991; Aeschli- 
mann et al., 1993; Sorensen et al., 1994). 
A prerequisite for the function of tissue transglutaminase 
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in matrix remodeling is its externalization to the extracellu- 
lar space. It is unlikely that tissue transglutaminase i  
secreted by the conventional p thway as the enzyme has a cy- 
toplasmic localization and lacks the characteristic features of 
secretory proteins, such as a signal peptide, glycosylation, 
and disulfide bonding, even though potential sites for such 
modifications are present in the sequence (for review see 
Aeschlimann and Paulsson, 1994). The present demonstra- 
tion of protein synthesis by chondrocytes also in the mineral- 
ized areas of tracheal cartilage is consistent with metabolic 
and proliferative activity of chondrocytes in the calcified ma- 
trix of long bones detected by incorporation of [35S]sulfate 
and pH]thymidine, respectively (Hunziker, 1992 and per- 
sonal communication), and shows that externalization f the 
transglutaminase in the mineralizing matrix is not due to cell 
death. This is further supported by the fact that DNA- 
fragmentation, which accompanies apoptotic ell death in 
most cases (F6sus et al., 1991), has not been observed in the 
growth plate cartilage of the developing chicken limb (V. 
Thomazy, personal communication). In contrast, tissue 
transglutaminase expression in the interdigital segment of 
the limb correlates with DNA fragmentation a d apoptosis. 
The fate of terminally differentiated chondrocytes remains 
uncertain (Gentili et al., 1993), but tissue transglutaminase 
externalization a d activation should be considered as part 
of the differentiation program of chondrocytes, independent 
from potential cell death. 
Since we and others failed todemonstrate widespread cell 
death and lysis in terminally differentiated cartilage, we con- 
clude that tissue transglutaminase i  externalized by an- 
other, not yet characterized mechanism. It has recently been 
shown that another transglutaminase family ember, pros- 
tate transglutaminase, though absent from endoplasmic re- 
ticulum and Golgi complex, is released in apocrine secretory 
vesicles from dorsal prostate and coagulating gland during 
copulation (Seitz et al., 1990). Prostate transglutaminase is 
therefore likely to enter the vesicles directly from the cyto- 
plasm. Membrane-bound vesicles with cytoplasm-derived 
contents shedded from the cell surface could similarly be re- 
sponsible for the externalization f tissue transglutaminase. 
So called matrix vesicles that are selectively enriched in cer- 
tain cytoplasmic proteins have been observed in many tis- 
sues, including cartilage (Hale and Wuthier, 1987). 
Tissue transglutaminase binds tightly to components of 
the pericellular matrix upon release (Upchurch et al., 1991) 
and probably acts by cross-linking the surrounding matrix 
upon activation at the elevated Ca 2÷ concentration met in 
the extracellular space. Fibrinogen and fibronectin bind to 
the surface of hepatocytes and endothelial cells in suspension 
culture and become cross-linked into the pericellular matrix 
by tissue transglutaminase (Barsigian et al., 1991). Extrac- 
tion of the tracheal cartilage after labeling with monodansyl- 
cadaverine in culture revealed a distinct set of labeled pro- 
teins. Among these, osteonectin and type II collagen were 
identified as predominantly labeled components. This find- 
ing is consistent with the previously observed amine incor- 
poration into osteonectin a d type II collagen in the transglu- 
taminase-catalyzed r action in vitro (Aeschlimann et al., 
1993) but, in addition, demonstrates that these proteins are 
physiological substrates for the transglutaminase. Moreover, 
a previously described ,,~43-kD protein that acts as glutaminyl 
substrate for endogenous transglutaminase in homogenates 
of bovine epiphyseal growth plate cartilage (Aeschlimann et 
al., 1993) appears to be osteonectin based on its elution in 
anion exchange and molecular sieve chromatography and on 
its immunological similarity (results not shown). Extraction 
of adult rat tracheal cartilage revealed, in addition to os- 
teonectin monomer, high molecular mass complexes that 
were resistant o reduction and immunoreactive for os- 
teonectin. The complexes with an apparent molecular mass 
of 90 and 175 kD probably represent cross-linked osteonec- 
tin oligomers ince similar complexes were formed upon 
cross-linking of osteonectin by tissue transglutaminase in 
vitro. In contrast, a major 65-kD complex gave the NH2- 
terminal sequence of osteonectin by Edman degradation, but 
was not formed by in vitro cross-linking. It is possible that 
the 65-kD complex results from cross-linking of osteonectin 
with another component, but the amounts of sample avail- 
able did not allow an unambiguous identification of such a 
component. 
The proteins cross-linked to osteonectin i  situ need to be 
further characterized and the sequence locations of the 
cross-linking sites identified. Once available, this informa- 
tion will provide an insight into the physiological interaction 
partners of osteonectin and into the organization of the cal- 
cifying matrix. Osteonectin may bind to collagens (Sage et 
al., 1989; Mayer et al., 1991) and influence calcium phos- 
phate deposition in the mineralization process in cartilage 
and bone (Termine t al., 1981b; Engel et al., 1987; Maurer 
et al., 1992). The present demonstration of the trans- 
glutaminase cross-link in bone matrix, the isolation of cross- 
linked osteonectin complexes from long bones and the previ- 
ously reported presence of transglutarninase activity in 
newly deposited osteoid (Aeschlimann et al., 1993) indicate 
a more general role for transglutaminase cross-linking 
in skeletal tissues, even though the enzymes involved in 
bone and cartilage may be different members of the trans- 
glutaminase protein family (Aeschlimann etal., 1993). Dif- 
ferential posttranslational modification (Kelm and Mann, 
1991) may serve to regulate the diverse biological functions 
proposed for osteonectin different issues (Clezardin et 
al., 1988; Mayer et al., 1991; Sage and Bornstein, 1991) and 
transglutaminase cross-linking may indeed alter the proper- 
ties of the protein either by amine incorporation rformation 
of protein complexes. 
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